Lactic acid-producing bacteria (LAB) probiotics demonstrate immunomodulating and anti-inflammatory effects and the ability to lessen the symptoms of arthritis in both animals and humans. This randomized, double-blind, placebo-controlled, parallel-design, clinical pilot trial was conducted to evaluate the effects of the LAB probiotic preparation, Bacillus coagulans GBI-30, 6086, on symptoms and measures of functional capacity in patients with rheumatoid arthritis (RA) in combination with pharmacological anti-arthritic medications.
Read the full study here
Cardiology
Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation
Cardiology
Probiotic characteristics of Bacillus coagulans and associated implications for human health and diseases
Covid-19
The potential application of probiotics and prebiotics for the prevention and treatment of COVID-19
Endocrinology
Probiotic characteristics of Bacillus coagulans and associated implications for T human health and diseases
Gastroenterology
Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS
General Studies
“King Of Probiotics” Bacillus Coagulans In Modern Combined Probiotic Preparations Laktovit Forte
Gynecology
New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress
Gynecology
Dietary Antioxidant Intake and Human Papillomavirus Infection: Evidence from a Cross-Sectional Study in Italy
Immune System
Original Research: A Patented Strain of Bacillus coagulans Increased Immune Response to Viral Challenge
Orthopaedics
Does Administration of Vitamin C Improves Osteoporosis in Post-Menopausal Women- A Single Center Randomized Case Control Study
Orthopaedics
Is Zinc an Important Trace Element on Bone-Related Diseases and Complications? A Meta-analysis and Systematic Review from Serum Level, Dietary Intake, and Supplementation Aspects
Orthopaedics
Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial
Pediatrics
Bacillus coagulans GBI-30, 6068 decreases upper respiratory and T gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins
Subscribe to our monthly newsletter